Company · CIK 0001785530 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Werewolf Therapeutics, Inc. · HOWL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 SForm 4 → | Jul 8, 5:34 pm EDT | Luke EvninDirector | 143,199 | $0.3125 | $44,749 | 0 | −100% | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 29, 7:07 pm EDT | Luke EvninDirector | 157,084 | $0.30 | $47,125 | 143,199 | −52.3% | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 22, 6:59 pm EDT | RA CAPITAL MANAGEMENT, L.P. +310% Owner | 416,911 | $0.35 | $145,919 | 303,719 | −57.9% | |
| Jun 12, 2026 SForm 4 → | Jun 16, 6:01 pm EDT | RA CAPITAL MANAGEMENT, L.P. +310% Owner | 448,836 | $0.3871 | $173,758 | 331,414 | −57.5% | |
| Jun 9, 2026 SForm 4 → | Jun 11, 8:13 pm EDT | RA CAPITAL MANAGEMENT, L.P. +310% Owner | 678,226 | $0.3739 | $253,569 | 361,229 | −65.2% | |
| Jun 9, 2026 SForm 4 → | Jun 10, 5:20 pm EDT | Luke EvninDirector | 76,928 | $0.37 | $28,463 | 300,283 | −20.4% | 10b5-1 |
| Jun 4, 2026 SForm 4 → | Jun 8, 6:13 pm EDT | Luke EvninDirector | 105,565 | $0.4076 | $43,029 | 377,211 | −21.9% | 10b5-1 |
| Jun 1, 2026 SForm 4 → | Jun 3, 6:42 pm EDT | Luke EvninDirector | 139,803 | $0.4551 | $63,628 | 482,776 | −22.5% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.